期刊
PHARMACOLOGICAL REPORTS
卷 74, 期 4, 页码 709-717出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s43440-022-00371-2
关键词
G protein-coupled receptor 35; GPR35; Colorectal cancer; Overall survival; Disease-specific survival; Biomarker
资金
- Medical University of Lodz [503/1-156-04/503-11-001-19]
- Foundation for Polish Science (FNP) [START 30.2021]
This study suggests that the expression of GPR35 is associated with survival rates in colorectal cancer patients and has prognostic value for male patients.
Background G protein-coupled receptor 35 (GPR35) is involved in the carcinogenesis; however, limited data exist on its relevance for overall survival (OS) and disease-specific survival (DSS) in patients with cancer. Methods We have examined The Cancer Genome Atlas dataset to check the relations between GPR35 expression pattern and OS or DSS of patients with colorectal cancer (CRC). Results The performed analysis showed a negative association between positive GPR35 expression Z score and OS in males, which remains statistically significant in advanced stages of colon (COAD) and rectal (READ) adenocarcinoma combined. Conclusions These findings suggest the prognostic value of early testing of GPR35 in male patients with an increased risk of CRC development and warrant further clinical confirmation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据